[Therapeutic maintenance level of methotrexate in rheumatoid arthritis].

Latifa Tahiri, N. Hajjaj‐Hassouni(International University of Rabat), R. Abouqal, Imane Jroundi(Ministère de la Santé), F. Allali(Délégation Paris 5)

PubMed

April 3, 2007

Cited by 9

Related Papers

Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study

|Annals of the Rheumatic Diseases|2015|268

Why we should definitely include intra-articular hyaluronic acid as a therapeutic option in the management of knee osteoarthritis: Results of an extensive critical literature review

|Seminars in Arthritis and Rheumatism|2018|164

High Prevalence of Hypovitaminosis D in Morocco: Relationship to Lifestyle, Physical Performance, Bone Markers, and Bone Mineral Density

|Seminars in Arthritis and Rheumatism|2008|154

Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor α

|Annals of the Rheumatic Diseases|2003|122

Sarcopenia in rheumatoid arthritis: prevalence, influence of disease activity and associated factors

|Rheumatology International|2017|114